The Global Wearable Injectors Market is Predict to reach $12.9 Billion by 2028, at a CAGR of 9.2%

Published Date: 31-May-2022

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Wearable Injectors Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Wearable Injectors Market size is expected to reach $12.9 billion by 2028, rising at a market growth of 9.2% CAGR during the forecast period.

The Diabetes segment acquired maximum revenue share in the Global Wearable Injectors Market by Therapy 2021, thereby, achieving a market value of $5.9 billion by 2028. The increased prevalence of diabetes around the world, together with the increasing availability of wearable injectors for the diagnosis of chronic diseases, is driving the expansion of this market segment. The rapidly rising incidences of diabetes across the world are a result of significant lifestyle changes in people. Moreover, another factor driving the development of diabetes in people is the adoption of a sedentary lifestyle along with a lack of physical activities. This factor is augmenting the growth of the segment.

The Home healthcare setting segment is showcasing a CAGR of 11.8% during (2022 - 2028). The growth of the segment is rising due to the increased preference for self-administration of medication, as well as the growing need to reduce healthcare expenses. Furthermore, the growing need for technologically sophisticated drug administration approaches that reduce hospitalization rates while requiring minimum expertise is likely to propel the utilization of wearable injectors in home healthcare settings.

The On-body Injector segment is leading the Global Wearable Injectors Market by Type 2021, thereby, achieving a market value of $8.7 billion by 2028. The increasing growth of this segment can be attributed to the patients' ease to deliver a precise amount of drug to the body over a controlled period of time. Moreover, the convenience that is offered by this technique is another factor that is estimated to propel the growth of the segment in the forecast period.

The Motor Based segment has shown growth rate of 9.5% during (2022 - 2028). The constantly increasing growth of the segment is owing to the integration of advanced high-end motors into these injectors, which allow users to immediately inject the required amount of medicine into their body. This factor is augmenting the growth of this segment.

The North America market dominated the Global Wearable Injectors Market by Region 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $5 billion by 2028. The Europe market is estimated to witness a CAGR of 9% during (2022 - 2028). Additionally, The Asia Pacific market would experience a CAGR of 9.8% during (2022 - 2028).

Full Report:

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Insulet Corporation, United Therapeutics Corporation, ATS Automation Tooling Systems, Inc., Ypsomed AG, Amgen, Inc., West Pharmaceutical Services, Inc., Zealand Pharma A/S (Valeritas, Inc.), Medtronic PLC, CeQur SA, and Subcuject ApS.

Global Wearable Injectors Market Segmentation

By Therapy

  • Diabetes
  • Cardiovascular disease
  • Immuno-oncology
  • Others

By End User

  • Hospitals & Clinics
  • Home healthcare setting

By Type

  • On-body Injector
  • Off-body Injector

By Technology

  • Spring Based
  • Motor Based
  • Rotary pump
  • Expanding battery
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Insulet Corporation
  • United Therapeutics Corporation
  • ATS Automation Tooling Systems, Inc.
  • Ypsomed AG
  • Amgen, Inc.
  • West Pharmaceutical Services, Inc.
  • Zealand Pharma A/S (Valeritas, Inc.)
  • Medtronic PLC
  • CeQur SA
  • Subcuject ApS

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

North America Wearable Injectors Market Size & Opportunities 2022-2028

Europe Wearable Injectors Market & Growth Forecast 2022-2028

Asia Pacific Wearable Injectors Market Share & Industry Outlook to 2028

LAMEA Wearable Injectors Market Growth, Trends & Forecasts 2022-2028

Request a Free Sample Copy

Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.